Cover Image

Xanthohumol improves cognition in farnesoid X receptor-deficient mice on a high-fat diet

Saved in:

Bibliographic Details
Main Authors:	Payel Kundu (Author), Ines L. Paraiso (Author), Jaewoo Choi (Author), Cristobal L. Miranda (Author), Chrissa Kioussi (Author), Claudia S. Maier (Author), Gerd Bobe (Author), Jan F. Stevens (Author), Jacob Raber (Author)
Format:	Book
Published:	The Company of Biologists, 2022-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Xanthohumol ameliorates Diet-Induced Liver Dysfunction via Farnesoid X Receptor-Dependent and Independent Signaling
by: Ines L. Paraiso, et al.
Published: (2021)

ApoE isoform-dependent effects of xanthohumol on high fat diet-induced cognitive impairments and hippocampal metabolic pathways
by: Payel Kundu, et al.
Published: (2022)

Properties of Dry Hopped Dark Beers with High Xanthohumol Content
by: Justyna Paszkot, et al.
Published: (2021)

Vegetarian diets and risk of all-cause mortality in a population-based prospective study in the United States
by: Keeley Blackie, et al.
Published: (2023)

Protective effects of Xanthohumol against diabetic nephropathy in a mouse model
by: Fenglin Li, et al.
Published: (2023)

Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration
by: Guodong Li, et al.
Published: (2015)

Choline-deficient High-fat Diet-induced Steatohepatitis in BALB/c Mice
by: Saut Horas Hatoguan Nababan, et al.
Published: (2021)

Differential Inhibite Effect of Xanthohumol on HepG2 Cells and Primary Hepatocytes
by: Xiuli Zhang, et al.
Published: (2022)

Determination of the binding mode for anti-inflammatory natural product xanthohumol with myeloid differentiation protein 2
by: Fu W, et al.
Published: (2016)

Sensitivity of mice to lipopolysaccharide is increased by a high saturated fat and cholesterol diet
by: Stevens Rachel L, et al.
Published: (2007)

Irisin Is Controlled by Farnesoid X Receptor and Regulates Cholesterol Homeostasis
by: Hong Li, et al.
Published: (2019)

Farnesoid X Receptor Agonists as Therapeutic Target for Cardiometabolic Diseases
by: Chao Li, et al.
Published: (2020)

Role of Fasting Mimicking Diet in Farnesoid x Receptor for Suppressing Epithelial-to-Mesenchymal Transition, Cell Cycle Progression, and Viability of Prostate Cancer Cells
by: Wrood Salim, et al.
Published: (2023)

Resistance to Obesity in SOD1 Deficient Mice with a High-Fat/High-Sucrose Diet
by: Atsushi Sato, et al.
Published: (2022)

Role of farnesoid X receptor and bile acids in alcoholic liver disease
by: Sharon Manley, et al.
Published: (2015)

Natural Products Targeting Liver X Receptors or Farnesoid X Receptor
by: Jianglian She, et al.
Published: (2022)

Inadequate fat diet
by: A. P. Levitsky, et al.
Published: (2020)

Anticancer Activity and Mechanism of Xanthohumol: A Prenylated Flavonoid From Hops (Humulus lupulus L.)
by: Chuan-Hao Jiang, et al.
Published: (2018)

Potential of essential fatty acid deficiency with extremely low fat diet in lipoprotein lipase deficiency during pregnancy: A case report
by: Anderson Gregory J, et al.
Published: (2004)

Endothelin receptor B-deficient mice are protected from high-fat diet-induced metabolic syndrome
by: Martina Feger, et al.
Published: (2024)

The Novel Compounds That Activate Farnesoid X Receptor: the Diversity of Their Effects on Gene Expression
by: Takuo Suzuki, et al.
Published: (2008)

Potential of guggulsterone, a farnesoid X receptor antagonist, in the prevention and treatment of cancer
by: Sosmitha Girisa, et al.
Published: (2020)

The Preventive Effects of Xanthohumol on Vascular Calcification Induced by Vitamin D<sub>3</sub> Plus Nicotine
by: Shu-Fen Liou, et al.
Published: (2020)

Fat, diet, and intracranial atherosclerosis
by: Jiamei Shen, et al.
Published: (2016)

PPARγ Transcription Deficiency Exacerbates High-Fat Diet-Induced Adipocyte Hypertrophy and Insulin Resistance in Mice
by: Fusheng Guo, et al.
Published: (2020)

Hepatocyte-specific PKCβ deficiency protects against high-fat diet-induced nonalcoholic hepatic steatosis
by: Yaoling Shu, et al.
Published: (2021)

Role of farnesoid X receptor in establishment of ontogeny of phase-I drug metabolizing enzyme genes in mouse liver
by: Lai Peng, et al.
Published: (2016)

Farnesoid X receptor contributes to body weight-independent improvements in glycemic control after Roux-en-Y gastric bypass surgery in diet-induced obese mice
by: Kun Li, et al.
Published: (2020)

Probucol ameliorates hepatic stellate cell activation and autophagy is associated with farnesoid X receptor
by: Ruhui Yang, et al.
Published: (2019)

Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer
by: Mengjiao Zhou, et al.
Published: (2022)

Protective signature of xanthohumol on cognitive function of APP/PS1 mice: a urine metabolomics approach by age
by: Wei Liu, et al.
Published: (2024)

Xanthohumol Attenuated Inflammation and ECM Degradation by Mediating HO-1/C/EBPβ Pathway in Osteoarthritis Chondrocytes
by: Ming Zhang, et al.
Published: (2021)

Development of Guar Gum-Pectin-Based Colon Targeted Solid Self-Nanoemulsifying Drug Delivery System of Xanthohumol
by: Mahesh Hanmantrao, et al.
Published: (2022)

Vitamin C Deficiency Exacerbates Dysfunction of Atherosclerotic Coronary Arteries in Guinea Pigs Fed a High-Fat Diet
by: Gry Freja Skovsted, et al.
Published: (2022)

Altered pancreatic islet morphology and function in SGLT1 knockout mice on a glucose-deficient, fat-enriched diet
by: Markus Mühlemann, et al.
Published: (2018)

High-Fat High-Saturated Diet
Published: (2022)

Influence of fat-free, fat and sucrose diets on rat periodont condition
by: T. I. Pupin
Published: (2021)

Strong Antimicrobial Effects of Xanthohumol and Beta-Acids from Hops against <i>Clostridioides difficile</i> Infection In Vivo
by: Radek Sleha, et al.
Published: (2021)

Xanthohumol alleviates oxidative stress and impaired autophagy in experimental severe acute pancreatitis through inhibition of AKT/mTOR
by: Yaru Huangfu, et al.
Published: (2023)

Repositioning an Immunomodulatory Drug Vidofludimus as a Farnesoid X Receptor Modulator With Therapeutic Effects on NAFLD
by: Yanlin Zhu, et al.
Published: (2020)